Skip to content
Do you have adblock enabled?
 
If you can read this, either the style sheet didn't load or you have an older browser that doesn't support style sheets. Try clearing your browser cache and refreshing the page.

(NPR)   A new Alzheimer's drug didn't cause bleeding brains in 4/5 patients   (npr.org) divider line
    More: Interesting, Alzheimer's disease, Clinical trial, experimental drug, Dr. Madhav Thambisetty of the National Institute, infusions of lecanemab, Dr. Christopher van Dyck, Cognition, rate of cognitive decline  
•       •       •

406 clicks; posted to STEM » on 30 Nov 2022 at 3:30 PM (16 weeks ago)   |   Favorite    |   share:  Share on Twitter share via Email Share on Facebook



Voting Results (Smartest)
View Voting Results: Smartest and Funniest

 
2022-11-30 4:08:20 PM  
1 vote:
People who got infusions of lecanemab scored about half a point better on a zero-to-18-point scale of mental functioning, a slight but statistically significant difference.

Question is, how far behind normal people are Alzheimer patients (or at least, Alzheimer patients at this stage of the disease) on this scale? If it's 1 or 2 points, then maybe that's a pretty big deal; if it's 10 points, it seems like it's not worth the risk.
 
2022-11-30 4:24:26 PM  
1 vote:

Arkanaut: People who got infusions of lecanemab scored about half a point better on a zero-to-18-point scale of mental functioning, a slight but statistically significant difference.

Question is, how far behind normal people are Alzheimer patients (or at least, Alzheimer patients at this stage of the disease) on this scale? If it's 1 or 2 points, then maybe that's a pretty big deal; if it's 10 points, it seems like it's not worth the risk.


I think the NYTimes article said it slowed the progression by 27%.
 
Displayed 2 of 2 comments

View Voting Results: Smartest and Funniest

This thread is closed to new comments.

Continue Farking




On Twitter


  1. Links are submitted by members of the Fark community.

  2. When community members submit a link, they also write a custom headline for the story.

  3. Other Farkers comment on the links. This is the number of comments. Click here to read them.

  4. Click here to submit a link.